Yoganand Chillarige

Comparison of alpha-spending plans for near real-time monitoring for Guillain-Barré after influenza vaccination during the 2010/11 influenza season.

R. Ball, T. MaCurdy, A. Avagyan, 2020, Vaccine.

Patterns of seasonal influenza activity in U.S. core-based statistical areas, described using prescriptions of oseltamivir in Medicare claims data

C. Reed, D. Shay, R. Forshee, 2018, Epidemics.

Zostavax vaccine effectiveness among US elderly using real‐world evidence: Addressing unmeasured confounders by using multiple imputation after linking beneficiary surveys with Medicare claims

R. Forshee, T. MaCurdy, H. Izurieta, 2019, Pharmacoepidemiology and drug safety.

Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012–2013 and 2013–2014

D. Shay, R. Forshee, I. Foppa, 2017, The Journal of infectious diseases.

Recombinant Zoster Vaccine (Shingrix) real-world effectiveness in the first two years post-licensure.

R. Link-Gelles, R. Forshee, T. MaCurdy, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021.

G. D. Dal Pan, M. Bradley, S. Perez-Vilar, 2022, JAMA.